11 results
8-K
EX-99.1
LYEL
Lyell Immunopharma, Inc.
16 Dec 22
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
4:02pm
Sciences which gained marketing approval and launched ORGOVYX for men with advanced prostate cancer and MYFEMBREE for women with uterine fibroids
10-K
2021 FY
LYEL
Lyell Immunopharma, Inc.
29 Mar 22
Annual report
4:20pm
were self-reportedly approximately 52.1% percent women and 39% of our employees were self-reportedly ethnically or racially diverse with 25% Asian, 5
8-K
EX-99.2
uklwf1nqp9w8o
17 Dec 21
Lyell Immunopharma Announces cGMP Qualification of LyFE™ Manufacturing Center in Advance of Initiating Clinical Programs
4:02pm
424B4
e7k2cm4y1 mp
18 Jun 21
Prospectus supplement with pricing info
12:00am
S-1/A
6p5r gmcdj433b
9 Jun 21
IPO registration (amended)
7:12am
S-1
zijv1v1i0
25 May 21
IPO registration
5:28pm
DRS/A
tg0h 1dfgixloi4o
12 May 21
Draft registration statement (amended)
12:00am
DRS
782y3i3nk6g2s0vvc3v
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next